Adaptin Bio (APTN) Research & Development (2024 - 2026)

Adaptin Bio's Research & Development history runs 3 years deep, the most recent figure standing at $165577.0 for Q1 2026.

• In Q1 2026, Research & Development rose 166.49% year-over-year to $165577.0; the TTM figure through Mar 2026 stood at $1.9 million (up 11.25% YoY), while the FY2025 annual figure was $1.8 million, down 2.76% from the prior year.
• Research & Development came in at $165577.0 for Q1 2026 at Adaptin Bio, down from $593035.0 in the prior quarter.
• In the past five years, Research & Development ranged from a high of $778664.0 in Q3 2025 to a low of $62133.0 in Q1 2025.
• A 3-year average of $418259.3 and a median of $340334.0 in 2025 frame the typical range for Research & Development.
• Across the five-year window, Research & Development sank 68.77% in 2025 and surged 166.49% in 2026, its largest moves.
• Adaptin Bio's Research & Development stood at $258058.0 in 2024, then surged by 129.81% to $593035.0 in 2025, then tumbled by 72.08% to $165577.0 in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $165577.0, $593035.0, and $778664.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison